Pages that link to "Q45356317"
Jump to navigation
Jump to search
The following pages link to Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis (Q45356317):
Displaying 36 items.
- Current progress in gene delivery technology based on chemical methods and nano-carriers (Q28686380) (← links)
- Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection (Q33223738) (← links)
- Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation (Q33351784) (← links)
- Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. (Q33353872) (← links)
- MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis (Q33466750) (← links)
- Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis (Q33716157) (← links)
- Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant (Q33921967) (← links)
- Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation (Q34920323) (← links)
- Phosphoproteomics analysis of a clinical Mycobacterium tuberculosis Beijing isolate: expanding the mycobacterial phosphoproteome catalog (Q35067450) (← links)
- Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery (Q35190149) (← links)
- Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors (Q35207503) (← links)
- Current status of TB vaccines (Q36744717) (← links)
- A nonviral pHEMA chitosan nanosphere-mediated high-efficiency gene delivery system (Q36776952) (← links)
- High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine (Q36807329) (← links)
- Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection (Q36845307) (← links)
- Cationic liposomes as vaccine adjuvants (Q36968290) (← links)
- A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice (Q37124690) (← links)
- The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant (Q37956385) (← links)
- Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells (Q41835210) (← links)
- Short noncoding DNA fragments improve the immune potency of electroporation-mediated HBV DNA vaccination (Q42218604) (← links)
- Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity (Q43883863) (← links)
- Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. (Q45125454) (← links)
- Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation (Q45456530) (← links)
- Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. (Q46466695) (← links)
- Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice (Q46502373) (← links)
- Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection (Q46510361) (← links)
- Vaccine adjuvant: it makes the difference (Q47356302) (← links)
- Mycobacterium tuberculosis GroEL2 modulates dendritic cell responses (Q47407316) (← links)
- Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review (Q49874317) (← links)
- Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo (Q51801148) (← links)
- DNA vaccines against tuberculosis (Q57203104) (← links)
- Protective efficacy of different strategies employingMycobacterium lepraeheat-shock protein 65 against tuberculosis (Q58863716) (← links)
- TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants (Q59632262) (← links)
- A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge (Q64119526) (← links)
- Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity (Q79305608) (← links)
- A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis (Q97644982) (← links)